419 related articles for article (PubMed ID: 16904808)
1. Evaluation of HI 6 treatment after percutaneous VR exposure by use of a kinetic-based dynamic computer model.
Aurbek N; Thiermann H; Szinicz L; Worek F
Toxicology; 2007 Apr; 233(1-3):173-9. PubMed ID: 16904808
[TBL] [Abstract][Full Text] [Related]
2. Application of kinetic-based computer modelling to evaluate the efficacy of HI 6 in percutaneous VX poisoning.
Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F
Toxicology; 2006 Jul; 224(1-2):74-80. PubMed ID: 16740352
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of oxime efficacy in nerve agent poisoning: development of a kinetic-based dynamic model.
Worek F; Szinicz L; Eyer P; Thiermann H
Toxicol Appl Pharmacol; 2005 Dec; 209(3):193-202. PubMed ID: 15904945
[TBL] [Abstract][Full Text] [Related]
4. Simulation of cholinesterase status at different scenarios of nerve agent exposure.
Worek F; Eyer P; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):155-65. PubMed ID: 16904807
[TBL] [Abstract][Full Text] [Related]
5. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase.
Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F
Toxicology; 2006 Jul; 224(1-2):91-9. PubMed ID: 16720069
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in evaluation of oxime efficacy in nerve agent poisoning by in vitro analysis.
Worek F; Eyer P; Aurbek N; Szinicz L; Thiermann H
Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):226-34. PubMed ID: 17112559
[TBL] [Abstract][Full Text] [Related]
7. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
9. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality.
Eyer P; Szinicz L; Thiermann H; Worek F; Zilker T
Toxicology; 2007 Apr; 233(1-3):108-19. PubMed ID: 17010492
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of organophosphate-inhibited human, Cynomolgus monkey, swine and guinea pig acetylcholinesterase by MMB-4: a modified kinetic approach.
Worek F; Wille T; Aurbek N; Eyer P; Thiermann H
Toxicol Appl Pharmacol; 2010 Dec; 249(3):231-7. PubMed ID: 20888357
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose.
Shih TM; Skovira JW; O'Donnell JC; McDonough JH
Toxicol Mech Methods; 2009 Sep; 19(6-7):386-400. PubMed ID: 19778239
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of medical countermeasures against organophosphorus compounds: the value of experimental data and computer simulations.
Worek F; Aurbek N; Herkert NM; John H; Eddleston M; Eyer P; Thiermann H
Chem Biol Interact; 2010 Sep; 187(1-3):259-64. PubMed ID: 19917271
[TBL] [Abstract][Full Text] [Related]
14. An in vitro comparative study on the reactivation of nerve agent-inhibited guinea pig and human acetylcholinesterases by oximes.
Luo C; Tong M; Chilukuri N; Brecht K; Maxwell DM; Saxena A
Biochemistry; 2007 Oct; 46(42):11771-9. PubMed ID: 17900152
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of HI-6 DMS in a sustained infusion against percutaneous VX poisoning in the guinea-pig.
Whitmore C; Cook AR; Mann T; Price ME; Emery E; Roughley N; Flint D; Stubbs S; Armstrong SJ; Rice H; Tattersall JEH
Toxicol Lett; 2018 Sep; 293():207-215. PubMed ID: 29129798
[TBL] [Abstract][Full Text] [Related]
16. Lessons to be learnt from organophosphorus pesticide poisoning for the treatment of nerve agent poisoning.
Thiermann H; Szinicz L; Eyer P; Felgenhauer N; Zilker T; Worek F
Toxicology; 2007 Apr; 233(1-3):145-54. PubMed ID: 17161895
[TBL] [Abstract][Full Text] [Related]
17. Estimation of oxime efficacy in nerve agent poisoning: a kinetic approach.
Worek F; Szinicz L; Thiermann H
Chem Biol Interact; 2005 Dec; 157-158():349-52. PubMed ID: 16266695
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of oxime-induced reactivation of erythrocyte and muscle AChE from different animal species following inhibition by sarin or paraoxon.
Herkert NM; Aurbek N; Eyer P; Thiermann H; Worek F
Toxicol Lett; 2010 May; 194(3):94-101. PubMed ID: 20156534
[TBL] [Abstract][Full Text] [Related]
19. Medical treatment of acute poisoning with organophosphorus and carbamate pesticides.
Jokanović M
Toxicol Lett; 2009 Oct; 190(2):107-15. PubMed ID: 19651196
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship?
Aurbek N; Herkert NM; Koller M; Thiermann H; Worek F
Chem Biol Interact; 2010 Sep; 187(1-3):215-9. PubMed ID: 20105433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
